Cited by 51Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Guidelines for diagnosis and treatment of depression in older adults: a report from the Japanese Society of mood disorders.

Baba, Hajime, Kito, Shinsuke, Nukariya, Kazutaka, Takeshima, Minoru, Fujise, Noboru, Iga, Junichi, Oshibuchi, Hidehiro, Kawano, Masahiko +4 more·2022·Psychiatry and Clinical Neurosciences

Abstract

The Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders, published a Japanese guideline for the treatment of late‐life depression in 2020. Based on that guideline, the present guideline was developed and revised to incorporate the suggestions of global experts and the latest published evidence. In the diagnosis of late‐life depression, it is important to carefully differentiate it from bipolar disorders, depressive states caused by physical and organic brain disease, drug effects, and dementia, and to determine the comorbidity between late‐life depression and dementia. It is necessary to fully understand the clinical characteristics and psychosocial background of late‐life depression, evaluate the patient's condition, and provide basic interventions based on these factors. Problem‐solving therapy, reminiscence therapy/life review therapy, and behavioral activation therapy, and other forms of psychotherapy can reduce depressive symptoms. In terms of pharmacotherapy, newer antidepressants or non‐tricyclic antidepressants are recommended for late‐life depression, and it is recommended that the efficacy of least the minimal effective dosage should first be determined. Switching antidepressants and aripiprazole augmentation can be used to treatment‐resistant therapy. Electroconvulsive therapy and repetitive transcranial magnetic stimulation have demonstrated usefulness for late‐life depression. Exercise therapy, high‐intensity light therapy, and diet therapy also show some effectiveness and are useful for late‐life depression. Continuation therapy should be maintained for at least 1 year after remission.

Integrity signals

Registry

Crossref · 10.1111/pcn.13349

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

3 of the 168 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Baba, H., Kito, S., Nukariya, K., Takeshima, M., Fujise, N., Iga, J., Oshibuchi, H., Kawano, M., Kimura, M., Mizukami, K., Mimura, M., & Committee for Treatment Guidelines of Mood Disorders, J. S. O. M. D.
Affiliations
  • Juntendo University (JP)
  • Jikei University School of Medicine (JP)
  • Tokyo Medical University (JP)
  • Kumamoto University (JP)
  • Department of Neuropsychiatry Ehime University Graduate School of Medicine Ehime Japan
  • Kanagawa Children's Medical Center (JP)
  • Miyake Eye Hospital (JP)
  • Department of Neuropsychiatry Nippon Medical School, Chiba Hokusoh Hospital Chiba Japan
  • University of Tsukuba (JP)
  • Keio University (JP)
Corresponding author
Baba, Hajime
Venue
Psychiatry and Clinical Neurosciences
Publisher
Wiley
Published
2022-04-06
Volume
76
Issue
6
Pages
222-234
ISSN
  • 1323-1316 (ISSN-L)
  • 1440-1819
OpenAlex
W4220804164
Cited by
50
References
168
Citations by year
2026: 3 · 2025: 15 · 2024: 13 · 2023: 11 · 2022: 8
FWCI
7.18
Type
journal article
Language
en
Open access
closed
Locations
  • Psychiatry and Clinical Neurosciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Agency for Medical Research and Development (JP18dk0307060)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
geriatric depression, older adults, depression diagnosis, differential diagnosis, bipolar disorder, antidepressants, non-tricyclic antidepressants, treatment-resistant depression, electroconvulsive therapy, repetitive transcranial magnetic stimulation, psychotherapy, problem-solving therapy, reminiscence therapy, life review therapy, behavioral activation, exercise therapy, phototherapy, dietary therapy, continuation treatment
MeSH terms
Aged, Antidepressive Agents, Dementia, Depression, Humans, Japan, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review